Claret Capital Partners
Debt fund / VC / PE · London · United Kingdom
Etapas
Región de inversión
Industrias
Perfil
Claret Capital Partners is a growth debt investor based in London, founded in 2013. With a team expanding into Paris and Berlin, the firm is focused on providing flexible financing solutions to its portfolio companies. The team, including Managing Partner Johan Kampe, prides itself on addressing the needs of entrepreneurs seeking non-dilutive capital solutions in a selective equity market environment. Claret sets itself apart with discretionary co-investment partnerships that allow it to participate in larger deals. Claret focuses on technology, life sciences, and impact sectors, offering tailored growth capital solutions without demanding significant equity dilution. It invests across Europe, primarily targeting expansion, acquisitions, and product development financing needs. Since its inception, the firm has raised €1.3 billion and deployed over €1.5 billion. Notable funds include the €297 million Fund III closed in 2022 and the recently closed €575 million Fund IV. The firm's investor base comprises pension funds, insurers, family offices, and institutional investors. Some of the firm's notable portfolio companies include Billie - B2B payments platform, Cinclus Pharma - pharmaceuticals, Inventiva - biotech, and Surfe - sales intelligence platform. Additionally, Fund III supported companies like Cytora and Endomag. The firm continues to seek out and develop strategic partnerships to enhance its financing capabilities across Europe.
Contactos (2)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.